Structure Therapeutics
Specializes in the discovery and development of drugs against a type of targets called GPCR.
Launch date
Employees
Market cap
€2.1b
Enterprise valuation
€1.3b (Public information from Sep 2024)
Share price
$38.75 GPCR
South San Francisco California (HQ)
Authorizing premium user...